To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of Web-Assisted Peer Education for Early Diagnosis of Breast Cancer on Health Beliefs, Knowledge Levels and Breast Self-Examination in University Students
NCT ID:
NCT06112158
Condition:
University Students
Breast Self-examination
Health Education
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
Breast self-examination
Health Education
University students
Breast cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
Two groups with randomized controlled trial
Primary purpose:
Screening
Masking:
Single (Participant)
Masking description:
Web-supported and face-to-face training on breast cancer information and screening will
be provided to the experimental group.and outcome assessments will be performed by a
investigator who was blinded to group allocation.
Intervention:
Intervention type:
Behavioral
Intervention name:
Education Intervention
Description:
The BSE training program for the early diagnosis of breast cancer will be offered to
students in two ways: face-to-face and via web support.
Content of training Session 1: Topics such as the structure of the breast, the definition
of breast cancer, its prevalence, risk factors and symptoms Session 2: Teaching the
importance of early diagnosis in breast cancer, the importance and benefits of BSE, the
technique of performing BSE, the obstacles to the application of BSE.
Session 3: Teaching the risk factors that cause breast cancer. Session 4: Discussion of
case reports of patients diagnosed with breast cancer. Supporting education with web
support
Arm group label:
Education Intervention
Summary:
The aim of this study was to examine the effect of web-supported peer education on health
beliefs, knowledge levels and breast self-examination in university students.
Detailed description:
In line with the general purpose of the study, an experimental design will be used in the
study. The population of this study consists of female students of Ankara Medipol
University. Considering that there may be dropouts from the study in line with the
determined sample size, 200 students (intervention; n=100, control; n=100) who were
excluded from the exclusion criteria and who agreed to participate in the study were
planned to constitute the study group.
Hypotheses of the Research Between the experimental group and the control group, which
received peer education on breast cancer and Breast Self-Examination (BSE); H1a1: There
is a difference in terms of the sensitivity subscale score average. H1b1: There is a
difference in terms of the mean score of the seriousness/importance subscale.
H1c1: There is a difference in terms of the average score of the benefit perception
subscale.
H1d1: There is a difference in terms of the average score of the obstacle perception
subscale.
H1e1: There is a difference in terms of the mean score of the trust subscale. H1f1: There
is a difference in terms of the health motivation subscale score average.
H2a1: There is a difference in terms of the average knowledge score. H3a1: There is a
difference in terms of performing breast self-examination.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Young women who do not have any diagnosis of cancer or breast cancer
- who have no communication barriers
- who are not pregnant or breastfeeding
- who volunteer to participate in the study
Exclusion Criteria:
- Participants with a previous cancer diagnosis
- CHCMM training and who were absent for more than two sessions in the intervention
group
Gender:
Female
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Ankara Medipol Unıversty
Address:
City:
Ankara
Zip:
06000
Country:
Turkey
Status:
Recruiting
Contact:
Last name:
Esra Özer, Asisst. Prof.
Phone:
+905433630475
Email:
esra.ozer@ankaramedipol.edu.tr
Investigator:
Last name:
Yeşim Çetinkaya, Lecturer
Email:
Sub-Investigator
Start date:
March 13, 2024
Completion date:
June 30, 2024
Lead sponsor:
Agency:
Esra ÖZER
Agency class:
Other
Collaborator:
Agency:
Ankara Medipol University
Agency class:
Other
Source:
Ankara Medipol University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06112158
